Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis

Ayman Sayyed, Hyewon Lee, Taehyung Simon Kim, Jaeyoon John Kim, Danielle Pyne, Nathali Kaushansky, Yardena Brilon, Noa Chapal-Ilani, Tamir Biezuner, Liran I. Shlush, Jan Storek, Dennis Dong Hwan Kim

Blood (2023) 142 (Supplement 1): 2207.

https://doi.org/10.1182/blood-2023-191191

Published: 2023

Journal Articles

The ELN 2022 Risk Stratification Has No Impact on the Dismal Prognosis of Patients with Acute Undifferentiated Leukemia

Baher Krayem, Tsila Zuckerman, Avraham Frisch, Ilana Slouzkey, Tehila Azoulay, Michal Karmona, Liran I. Shlush, Nathali Kaushansky, Noa Chapal-Ilani, Shimrit Ringelstein-Harlev

Blood (2023) 142 (Supplement 1): 4221.

https://doi.org/10.1182/blood-2023-188592

Published: 2023

Journal Articles

Unraveling at Diagnosis Chemoresistant Relapse-Initiating Clones in Acute Myeloid Leukemia: Combined Functional and Genomic Analyses Using Single-Cell-Derived Hematopoietic Stem and Progenitor Cell Subpopulations

Tsila Zuckerman, Tal Gabay, Nofar Stolero, Niv Rabhun, Rawan Sabah, Ofir Raz, Yaara Neumeier, Zipora Marx, Liming Tao, Tamir Biezuner, Shiran Amir, Rivka Adar, Ron Levy, Noa Chapal Ilani, Liran I. Shlush, Ehud Shapiro, Shlomit Yehudai-Reshef

Blood (2022) 140 (Supplement 1): 8584–8585.

https://doi.org/10.1182/blood-2022-165068

Published: 2022

Journal Articles

Fatty Bone Marrow Positively Selects Pre-Leukemic HSPCs with a DNMT3A- mutation

Naama Zioni, Noa Chapal Ilani, Ekaterina Petrovich-Kopitman, Mehmet Saçma, Hartmut Geiger, Marina Scheller, Carsten Mueller-Tidow, Nathali Kaushansky, Liran I. Shlush

Blood (2021) 138 (Supplement 1): 596.

https://doi.org/10.1182/blood-2021-149360

Published: 2021

Journal Articles

Dasatinib Inhibits FLT3 /ITD and PTPN11 mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

Sigal Tavor, MD, Tali Shalit, PhD, Noa Chapal Ilani, PhD, Yoni Moskovitz, PhD, Nir Livnat, BSc, Yoram Groner, PhD, Haim Bar, PhD, Alexander Plotnikov, PhD, Nathali Kaushansky, PhD, Liran I. Shlush, MD

Blood (2019) 134 (Supplement_1): 1451.

https://doi.org/10.1182/blood-2019-128016

Published: 2019

Journal Articles

Long Term AML Survivors Have Increased Mortality and High Prevalence of Clonal Hematopoiesis

Noa Chapal Ilani, PhD, Elisabeth Niemeyer, MD, Netta Mendelson Cohen, PhD, Yoni Moskovitz, PhD, Barak Oron, Amanda Mitchell, PhD, Mark D. Minden, MD PhD, Amos Tanay, PhD, Ran Balicer, MD PhD, Tamir Biezuner, PhD, Daniela Cilloni, MD PhD, Klaus H. Metzeler, MD, Yishai Ofran, MD, Nathali Kaushansky, PhD, Liran I. Shlush, MD PhD

Blood (2018) 132 (Supplement 1): 1287.

https://doi.org/10.1182/blood-2018-99-116599

Published: 2018

Journal Articles

Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability

Liran I. Shlush, Noa Chapal-Ilani, Rivka Adar, Neta Pery, Yosef Maruvka, Adam Spiro, Roni Shouval, Jacob M. Rowe, Maty Tzukerman, Dani Bercovich, Shai Izraeli, Guido Marcucci, Clara D. Bloomfield, Tsila Zuckerman, Karl Skorecki, Ehud Shapiro

Blood (2012) 120 (3): 603–612.

https://doi.org/10.1182/blood-2011-10-388629

Published: 2012

Includes: Supplemental data

NARROW

The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis

The ELN 2022 Risk Stratification Has No Impact on the Dismal Prognosis of Patients with Acute Undifferentiated Leukemia

Unraveling at Diagnosis Chemoresistant Relapse-Initiating Clones in Acute Myeloid Leukemia: Combined Functional and Genomic Analyses Using Single-Cell-Derived Hematopoietic Stem and Progenitor Cell Subpopulations

Fatty Bone Marrow Positively Selects Pre-Leukemic HSPCs with a DNMT3A- mutation

Dasatinib Inhibits FLT3 /ITD and PTPN11 mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

Long Term AML Survivors Have Increased Mortality and High Prevalence of Clonal Hematopoiesis

Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability

Email alerts

ASH Publications

American Society of Hematology

The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis

The ELN 2022 Risk Stratification Has No Impact on the Dismal Prognosis of Patients with Acute Undifferentiated Leukemia

Unraveling at Diagnosis Chemoresistant Relapse-Initiating Clones in Acute Myeloid Leukemia: Combined Functional and Genomic Analyses Using Single-Cell-Derived Hematopoietic Stem and Progenitor Cell Subpopulations

Fatty Bone Marrow Positively Selects Pre-Leukemic HSPCs with a DNMT3A- mutation

Dasatinib Inhibits FLT3 /ITD and PTPN11 mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

Long Term AML Survivors Have Increased Mortality and High Prevalence of Clonal Hematopoiesis

Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only